Tharimmune, Inc.
THAR
$4.72
-$0.25-5.03%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -5.01% | 47.70% | 14.53% | 16.71% | 3.03% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -22.01% | 8.49% | 52.00% | 109.51% | 0.38% |
Operating Income | 22.01% | -8.49% | -52.00% | -109.51% | -0.38% |
Income Before Tax | 20.21% | -12.66% | -54.44% | -108.55% | 0.50% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 20.21% | -12.66% | -54.44% | -108.55% | 0.50% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 20.21% | -12.66% | -54.44% | -108.55% | 0.50% |
EBIT | 22.01% | -8.49% | -52.00% | -109.51% | -0.38% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | 73.32% | 61.22% | 79.99% | 93.78% | 95.36% |
Normalized Basic EPS | 73.32% | 61.21% | 79.99% | 93.78% | 95.36% |
EPS Diluted | 73.32% | 61.22% | 79.99% | 93.78% | 95.36% |
Normalized Diluted EPS | 73.32% | 61.21% | 79.99% | 93.78% | 95.36% |
Average Basic Shares Outstanding | 199.06% | 190.47% | 671.94% | 3,249.13% | 2,042.76% |
Average Diluted Shares Outstanding | 199.06% | 190.47% | 671.94% | 3,249.13% | 2,042.76% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |